Back to top

Technical picture remains unchanged for CHRS after it rises 0.72% on July 17

Coherus BioSciences, Inc. (CHRS) Technical Analysis, Stock Scans & Trading Signals · Jul 17, 2026, 17:40 ET
CHRS posted a 0.72% gain on Friday, July 17th, accompanied by 0.5× normal trading volume. Key support levels exist at 1.37, 1.34 & 1.32, with resistance at 1.42, 1.44 & 1.47. Additionally, Slow Stochastic points to oversold territory, hinting at a potential consolidation.

Current SwingTradeBot Technical Rating of CHRS: F

Is this the only signal? Not even close. Explore the full breakdown at SwingTradeBot.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Coherus Oncology, Inc. (CHRS)